Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.70%
#2 0G 0G +28.35%
#3 Fake World Assets Fake World Assets +21.19%
#4 Nockchain Nockchain +19.03%
#5 Full Moon Full Moon +17.70%
#6 Zora Zora +17.60%
#7 SAFEcoin SAFEcoin +17.38%
#8 Notcoin Notcoin +16.69%
#9 Axelar Axelar +15.62%
#10 ADO Protocol ADO Protocol +15.45%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Peringkat dalam Saham #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Harga Saham
$8.46
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$514.33M
Perubahan (1 hari)
-2.08%
Perubahan (1 tahun)
128.03%
Negara
US
Perdagangan Kyverna Therapeutics, Inc. (KYTX)

Kategori

Healthcare
EPS untuk Kyverna Therapeutics, Inc. (KYTX)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Kyverna Therapeutics, Inc., EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Kyverna Therapeutics, Inc. dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH